Package 50242-108-01

{"route": ["SUBCUTANEOUS"], "spl_id": "e8a259ac-2a09-4026-823c-f23cbcba6a2b", "openfda": {"nui": ["N0000175078", "N0000175657", "N0000175531", "M0009499"], "unii": ["4F4X42SYQ6", "743QUY4VD8"], "rxcui": ["1927885", "1927890", "1927893", "1927894"], "spl_set_id": ["3e5b7e82-f018-4eaf-ae78-d6145a906b20"], "pharm_class_cs": ["Glycoside Hydrolases [CS]"], "pharm_class_epc": ["CD20-directed Cytolytic Antibody [EPC]", "Endoglycosidase [EPC]"], "pharm_class_moa": ["CD20-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-108-01)  / 11.7 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "50242-108-01", "marketing_start_date": "20170622"}, {"sample": true, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-108-86)  / 11.7 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "50242-108-86", "marketing_start_date": "20170623"}], "brand_name": "Rituxan Hycela", "product_id": "50242-108_e8a259ac-2a09-4026-823c-f23cbcba6a2b", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["CD20-directed Antibody Interactions [MoA]", "CD20-directed Cytolytic Antibody [EPC]", "Endoglycosidase [EPC]", "Glycoside Hydrolases [CS]"], "product_ndc": "50242-108", "generic_name": "rituximab and hyaluronidase", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rituxan Hycela", "active_ingredients": [{"name": "HYALURONIDASE (HUMAN RECOMBINANT)", "strength": "2000 U/mL"}, {"name": "RITUXIMAB", "strength": "120 mg/mL"}], "application_number": "BLA761064", "marketing_category": "BLA", "marketing_start_date": "20170622", "listing_expiration_date": "20261231"}